Clinical trial
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00333125 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00333125 |
|---|---|
| Title | A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glaucoma, Ocular Hypertension |
| Intervention type | Drug, Other |
| Interventions | Travoprost 40 mcg/ml + Timolol 5 mg/ml eye drops, solution (DuoTrav), Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (Cosopt), Timolol Vehicle |
| Enrollment | 319 |
| Start date | Apr 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jun 2, 2006 |
| Last update posted | Nov 18, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: